Emerging roles of the gut microbiota in cancer immunotherapy
Zhuangzhuang Shi(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Zhi‐Yuan Zhou(Tsinghua University), Zhaoming Li(First Affiliated Hospital of Zhengzhou University), Wenting Song(Huazhong Agricultural University), Hongwen Li(Anhui Medical University)
Cited by 29
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
Altermagnets as a new class of functional materials
|Nature Reviews Materials|2025|200
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
|Digestive Diseases and Sciences|2011|140
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
|Journal of Hematology & Oncology|2018|134